Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Matrix-induced inhibition of membrane binding contributes to human immunodeficiency virus type 1 particle assembly defects in murine cells.
Hatziioannou T, Martin-Serrano J, Zang T, Bieniasz PD.
J Virol. 2005 Dec;79(24):15586-9.
Related citations
Retroviral matrix domains share electrostatic homology: models for membrane binding function throughout the viral life cycle.
Murray PS, Li Z, Wang J, Tang CL, Honig B, Murray D.
Structure. 2005 Oct;13(10):1521-31.
The effect of HIV-1 Gag myristoylation on membrane binding.
Provitera P, El-Maghrabi R, Scarlata S.
Biophys Chem. 2006 Jan 1;119(1):23-32. Epub 2005 Sep 23.
Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation.
Wu Z, Alexandratos J, Ericksen B, Lubkowski J, Gallo RC, Lu W.
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11587-92. Epub 2004 Jul 27.
A myristoyl switch regulates membrane binding of HIV-1 Gag.
Resh MD.
Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):417-8. Epub 2004 Jan 5. No abstract available.
Entropic switch regulates myristate exposure in the HIV-1 matrix protein.
Tang C, Loeliger E, Luncsford P, Kinde I, Beckett D, Summers MF.
Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):517-22. Epub 2003 Dec 29.
Role of myristylation in HIV-1 Gag assembly.
Bouamr F, Scarlata S, Carter C.
Biochemistry. 2003 Jun 3;42(21):6408-17.
Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding.
Lindwasser OW, Resh MD.
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13037-42. Epub 2002 Sep 20.
Myristoylation of human immunodeficiency virus type 1 gag protein is required for efficient env protein transportation to the surface of cells.
Shiraishi T, Misumi S, Takama M, Takahashi I, Shoji S.
Biochem Biophys Res Commun. 2001 Apr 20;282(5):1201-5.
Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.
Ono A, Freed EO.
J Virol. 1999 May;73(5):4136-44.
Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.
Paillart JC, Göttlinger HG.
J Virol. 1999 Apr;73(4):2604-12.
Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA.
Hermida-Matsumoto L, Resh MD.
J Virol. 1999 Mar;73(3):1902-8.
Blockage of N-myristoylation of HIV-1 gag induces the production of impotent progeny virus.
Furuishi K, Matsuoka H, Takama M, Takahashi I, Misumi S, Shoji S.
Biochem Biophys Res Commun. 1997 Aug 28;237(3):504-11.
Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.
Spearman P, Horton R, Ratner L, Kuli-Zade I.
J Virol. 1997 Sep;71(9):6582-92.
Differential membrane binding of the human immunodeficiency virus type 1 matrix protein.
Zhou W, Resh MD.
J Virol. 1996 Dec;70(12):8540-8.
Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding.
Morikawa Y, Hinata S, Tomoda H, Goto T, Nakai M, Aizawa C, Tanaka H, Omura S.
J Biol Chem. 1996 Feb 2;271(5):2868-73.
Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids.
Zhou W, Parent LJ, Wills JW, Resh MD.
J Virol. 1994 Apr;68(4):2556-69.
Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.
Lee PP, Linial ML.
J Virol. 1994 Oct;68(10):6644-54.
Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.
Göttlinger HG, Sodroski JG, Haseltine WA.
Proc Natl Acad Sci U S A. 1989 Aug;86(15):5781-5.
Chemical characterization of p17gag from human immunodeficiency virus as an N-terminally myristoylated protein.
Goddard C, Aquino A, Glazer RI, Felsted RL.
Eur J Biochem. 1989 Jun 15;182(2):323-6.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on